Functional aortic stiffness: role of CD4(+) T lymphocytes

Area of Science:

• Immunology
• Cardiovascular Physiology
• Vascular Biology

Background:

• The immune system, particularly lymphocytes, is implicated in vascular remodeling and stiffening.
• Understanding the specific contribution of lymphocytes to vascular stiffness is essential for developing targeted therapies.

Purpose of the Study:

• To investigate the role of lymphocytes in angiotensin II-induced vascular stiffening.
• To differentiate between vasoconstriction and vascular remodeling components of aortic stiffness.

Main Methods:

• Comparison of angiotensin II-induced vascular stiffening in normal C57BL/6J mice and lymphocyte-deficient RAG 1(-/-) mice.
• Assessment of aortic pulse wave velocity, effective wall stiffness, and effective Young's modulus.
• Adoptive transfer of CD4(+) T helper lymphocytes into RAG 1(-/-) mice.
• Analysis of vascular remodeling through morphometrics.

Main Results:

• Angiotensin II significantly increased aortic stiffness in normal mice but not in RAG 1(-/-) mice.
• Adoptive transfer of CD4(+) T helper cells restored angiotensin II-mediated aortic stiffening in RAG 1(-/-) mice.
• Angiotensin II-induced aortic stiffening resulted from the combined effects of vasoconstriction and vascular remodeling.

Conclusions:

• CD4(+) T-lymphocytes play a pivotal role in angiotensin II-mediated vascular stiffening.
• Lymphocytes are critical mediators of angiotensin II-induced changes in aortic stiffness.
• Angiotensin II promotes aortic stiffening through both active vasoconstriction and vascular remodeling processes.